BIXT — Bioxytran Cashflow Statement
0.000.00%
Last trade - 00:00- $5.82m
- $6.70m
Annual cashflow statement for Bioxytran, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.54 | -4.53 | -2.66 | -4.37 | -2.38 |
| Amortisation | |||||
| Non-Cash Items | 1.18 | 0.66 | 0.544 | 1.08 | 1.09 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.263 | 2.17 | 0.304 | 2.5 | 1.23 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -1.1 | -1.7 | -1.81 | -0.775 | -0.056 |
| Capital Expenditures | -0.01 | -0.037 | -0.032 | -0.044 | -0.028 |
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -0.01 | -0.037 | -0.032 | -0.044 | -0.028 |
| Financing Cash Flow Items | 0.95 | 0.6 | 0.68 | — | 0.063 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.981 | 1.76 | 2.06 | 0.55 | 0.063 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.128 | 0.031 | 0.223 | -0.269 | -0.021 |